Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathway

Xiaomei Sun(Chinese Academy of Sciences), Sumei Zhang(Anhui Medical University)
Oncology Letters
May 23, 2023
Cited by 6


Related Papers